Congress rushing to tackle rise in swatting cases involving officials

Congressional Security Officials ⁤Address Surge of ⁢Swatting Incidents

Congressional security officials are taking action⁣ to combat⁢ a sudden ⁤increase in dangerous swatting incidents targeting House members and their families.

On Monday, Rep. Shontel Brown (D-OH) joined ‍a ​growing list of Congress members who have reported swatting incidents. Others who⁢ have been targeted include Reps. Marjorie Taylor Greene (R-GA), Brandon ⁤Williams (R-NY), and Tom Emmer​ (R-MN), as well as Sen. Rick Scott (R-FL).

In a letter from House Sergeant at Arms William ⁣McFarland, addressed to⁤ the spouses of Congress members, ⁤instructions were provided‍ on how to handle swatting incidents.​ Additionally,‍ a virtual conference will be held​ soon to further educate and⁤ prepare⁣ individuals in‌ the event⁣ of ⁤a ⁤swatting incident.

“The Office of the Sergeant at Arms will be planning a virtual​ conference to discuss swatting with congressional staff,” the letter ​read. “In addition, I will personally ‍be ​on​ hand⁤ at⁢ the upcoming retreats,‌ and will be ⁤available for ⁣any ‌spouse wishing to discuss security matters.”

To prevent⁢ or prepare for swatting incidents, family members ⁢were urged to take several precautions, ‍including contacting the Sergeant at ⁤Arms Police Services Division to develop an⁤ action plan, enrolling​ in residential and cybersecurity‌ programs,‍ establishing contact with ​local law enforcement, and reporting any suspicious activity or swatting incidents.

Swatting involves an anonymous individual falsely reporting a violent or hostage situation at the targeted⁣ person’s residence, with the intention⁤ of ‌provoking a⁣ response from a SWAT team. This dangerous ‍act puts ⁣the lives of those inside the home at risk.

How do extended-release medications reduce the risk of certain side ‌effects compared to immediate-release versions

There are a few possible reasons why people might use extended-release medications.

1. Extended-release medications often​ provide longer-lasting relief than immediate-release‌ medications. This can be particularly‍ beneficial for chronic conditions where continuous symptom control is needed throughout the day or night. By delivering⁣ the medication slowly over an‍ extended period, these medications can help‌ maintain‍ a steady level of the drug in the body and provide more consistent relief.

2. Extended-release medications may reduce the frequency of dosing. Taking medication multiple ⁤times a day can be inconvenient and may increase the risk of missing doses. Extended-release formulations ⁤allow for less frequent dosing, typically once ⁢or twice a day, making it easier to​ adhere​ to the treatment regimen.

3. Extended-release medications may have a lower risk of side effects compared to immediate-release versions. The slower release of the drug can help minimize high peak plasma concentrations, which can reduce the risk of certain side effects. By maintaining a more stable drug concentration in the body, ​extended-release medications may provide a smoother and more​ tolerable pharmacokinetic profile.

4. Extended-release medications can help improve medication compliance. Patients who have difficulty remembering to take their medication at regular intervals may⁢ benefit from extended-release formulations. By reducing the number of doses required, these medications may improve adherence and overall​ treatment outcomes.

5. Extended-release medications​ can be more convenient for patients. Instead of needing ​to take medication throughout‌ the day, extended-release formulations allow for once-daily dosing or less frequent dosing,⁣ which can be more practical for individuals ‌with busy schedules or​ those who have‍ difficulty remembering to take medication regularly.

*As an Amazon Associate I earn from qualifying purchases